Cover Image

Anti-TNF alpha-induced paradoxical psoriasis treated with topical roflumilast 0.3%

Saved in:

Bibliographic Details
Main Authors:	Edith Hanna, MD (Author), Anissa Benchikh El Fegoun, MD (Author)
Format:	Book
Published:	Elsevier, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Management of scrotal pruritus with topical roflumilast 0.3% once daily treatment
by: Paul S. Yamauchi, MD, PhD
Published: (2024)

Topical roflumilast approved for psoriasis treatment
by: article Editorial
Published: (2022)

Refractory erythema annulare centrifugum treated with roflumilast
by: Pamela Calderon, BS, et al.
Published: (2024)

Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis
by: Jaqueline Barbeito de Vasconcellos, et al.
Published: (2016)

[Translated aticle] Topical and Oral Roflumilast in Dermatology: A Narrative Review
by: M. Mansilla-Polo, et al.
Published: (2024)

Possible Paradoxical Photosensitive Psoriasis Induced by Tumour Necrosis Factor-alpha Inhibitors
by: Pauline Bataille, et al.
Published: (2019)

Paradoxical psoriasis induced by TNF‐α blockade shows immunological features typical of the early phase of psoriasis development
by: Luca Fania, et al.
Published: (2020)

A comparative study in treatment of childhood vitiligo 0.03% tacrolimus versus 0.03% tacrolimus and topical steroids
by: Anandan Venkatesan, et al.
Published: (2021)

Paradoxical pustular psoriasis in a patient with spondyloarthritis treated with secukinumab
by: Daniela Anghel, et al.
Published: (2023)

A Review of the Categorizations of Mild, Moderate, and Severe Bacterial Keratitis Ulcers and Day-1 Treatment Regimen When Using the Topical Fluoroquinolones 0.3% Ciprofloxacin and 0.3% Ofloxacin
by: John Graham Pearce, PhD, et al.
Published: (2023)

Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
by: Giarmoukakis AK, et al.
Published: (2020)

Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
by: Zuzana Jiraskova Zakostelska, et al.
Published: (2023)

Successful Treatment of Recalcitrant Granuloma Gluteale Infantum with Topical Tacrolimus 0.03% Ointment
by: Alexander K. C. Leung, et al.
Published: (2021)

Oral roflumilast as a therapeutic option for psoriasis, what role does it have? Case report and literature review
by: Javier Gimeno Castillo, et al.
Published: (2023)

Vulnerable COPD patients with comorbidities: the role of roflumilast
by: Lipari M, et al.
Published: (2014)

Eyelid ptosis following botulinum toxin injection treated with briminodine 0.33% topical gel
by: Ghadah F. Alotaibi, MD, et al.
Published: (2022)

Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
by: Cristián Navarrete-Dechent, et al.
Published: (2015)

Comparative Study of Ocular Pharmacokinetics of Topical 0.3% Gatifloxacin Eye Gel and Solution in Rabbits
by: Manli Liu, et al.
Published: (2022)

Infantile psoriasis treated successfully with topical calcipotriene
by: Neerja Puri
Published: (2013)

Systematic review of TNFα-induced paradoxical psoriasis: Treatment outcomes of switching to alternative biologic therapies in inflammatory bowel disease patients
by: Rishab Revankar, et al.
Published: (2023)

Roflumilast: Review of Phosphodiesterase-4 Inhibitor as Asthma Therapy
by: Rafina Syfridiana, et al.
Published: (2021)

Identification of the Schistosoma mansoni TNF-alpha receptor gene and the effect of human TNF-alpha on the parasite gene expression profile.
by: Katia C Oliveira, et al.
Published: (2009)

Secukinumab-induced paradoxical palmoplantar pustular psoriasis
by: Yıldız Gürsel Ürün, et al.
Published: (2022)

Anti-TNF-Alpha Therapy and Systemic Vasculitis
by: Pierre-André Jarrot, et al.
Published: (2014)

Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
by: Mark A Giembycz, et al.
Published: (2010)

Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap
by: Zhang X, et al.
Published: (2018)

Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management
by: Cannizzaro MV, et al.
Published: (2017)

A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis
by: Zhou Q, et al.
Published: (2023)

Paradoxical Psoriasis: A Dermoscopic and Histopathologic Teaching Points
by: Marco Adriano Chessa, et al.
Published: (2024)

Roflumilast tópico y oral en dermatología. Una revisión narrativa
by: M. Mansilla-Polo, et al.
Published: (2024)

Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa
by: Carlo Alberto Vignoli, et al.
Published: (2023)

Topical 0.03% atropine vs. 15% aluminum chloride in treating multiple eccrine hidrocystomas: A randomized single blind controlled study
by: Amirhoushang Ehsani, et al.
Published: (2010)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
by: Kiss EV, et al.
Published: (2011)

Occupational therapy in rheumatoid arthritis: short term prospective study in patients treated with anti-TNF-alpha drugs
by: M. Gentili, et al.
Published: (2011)

Atopic Dermatitis as a Paradoxical Effect of Secukinumab for the Treatment of Psoriasis
by: Eduardo V. Mendes Roncada, et al.
Published: (2021)

Paradoxical tralokinumab-induced psoriasis in a patient with atopic dermatitis
by: Galina Balakirski, et al.
Published: (2023)

Effect of TNF-α −308G/A (rs1800629) Promoter Polymorphism on the Serum Level of TNF-α Among Iraqi Patients with Generalized Vitiligo
by: Ahmed R, et al.
Published: (2020)

The use of anti-TNFα medications for rheumatologic disease in pregnancy
by: Megan EB Clowse
Published: (2010)

Salivary TNF-alpha: A potential marker of periodontal destruction
by: Pritma Singh, et al.
Published: (2014)

Are there any positive effects of TNF-alpha blockers on bone metabolism?
by: A. Sulli, et al.
Published: (2011)